Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
Nissen-Druey
C
C
Department of Research, Kantonspital Basel, Switzerland.
D000380:Agranulocytosis / Q000188:drug therapy*; D000741:Anemia, Aplastic / Q000188:drug therapy*; D016026:Bone Marrow Transplantation; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004341:Drug Evaluation; D006085:Graft Survival / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D009369:Neoplasms / Q000150:complications; D009503:Neutropenia / Q000151:congenital / Q000188:drug therapy* / Q000209:etiology; D011289:Preleukemia / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor